ライフサイエンスコーパス: CT scan

1 m the PET tracer and 3.7 mSv from 1 low-dose CT scan).

2 the PET tracer and 3.7 mSv from one low-dose CT scan).

3 on correction based on a separately acquired CT scan.

4 rrelates with intracranial injury visible on CT scan.

5 l diagnostic accuracy of lung ultrasound and CT scan.

6 en, patients underwent a brain (18)F-FDG PET/CT scan.

7 and incidental subjects with a positive lung CT scan.

8 a previously acquired and motion-compensated CT scan.

9 d on the analysis of all slices of the chest CT scan.

10 started, followed by a 30-min whole-body PET/CT scan.

11 oma disease) underwent staging (18)F-FDG PET/CT scan.

12 ation of radiomics in clinical routine chest CT scans.

13 mL scored either 1 or 2 on (11)C-choline PET/CT scans.

14 fferent parenchymal feature classes from 208 CT scans.

15 nd two in-house datasets with a total of 238 CT scans.

16 ognize EGFR-mutant from EGFR-WT patients via CT scans.

17 ecologic oncology reviewed all (18)F-FDG PET/CT scans.

18 ation of (18)F-FDHT uptake in whole-body PET/CT scans.

19 mary endpoint, including a central review of CT scans.

20 mL scored either 1 or 2 on (11)C-choline PET/CT scans.

21 omography (CT) scans, and 5,710 with cardiac CT scans.

22 ysm (ATAA) patients from pre-operative gated CT scans.

23 ndent test set of 200 randomly selected head CT scans.

24 as a combined reading of MRI and dual-energy CT scans.

25 cted from 3318 nongated, unenhanced COPDGene CT scans.

26 oped to segment the spleen on thorax-abdomen CT scans.

27 APIs) generate high-contrast images with PET/CT scans.

28 of tracer was needed to obtain all four PET/CT scans.

29 nd/or N2 CC on baseline computed tomography (CT) scan.

30 based CRS also encompasses endoscopy and/or CT scanning.

31 (18)F-FDG pharmacokinetics using dynamic PET/CT scanning.

32 veillance strategy with serial (18)F-FDG PET/CT scanning.

33 tumors on preoperative computed tomography (CT) scan (2.3 vs 3.0 cm, P = 0.03), but no predictors of

34 osis, 58% had abdominal ultrasonography, 27% CT scan, 21% upper endoscopy, 13% colonoscopy and 83% a

35 cans of 52 patients (49 computed tomography (CT) scans; 26 magnetic resonance (MR) imaging scans).

36 tent clinical symptoms, computed tomography (CT) scan abnormalities, and Legionella detection in lowe

37 is method can be applied to routine clinical CT scans acquired from patients during their AAA surveil

38 All underwent (68)Ga-PSMA-11 PET/CT scans acquired from vertex to toes for primary stagin

39 NET patients underwent a 45-min dynamic PET/CT scan after injection of (68)Ga-DOTATOC or (68)Ga-DOTA

40 for 5 patients who completed at least 3 PET/CT scans after administration of (124)I-MIBG, we estimat

41 Data from mu-CT scans also show that neurological innervation of eyes

42 bed using a successful reconstruction from a CT-scan analysis to better observe some characters.

43 extracorporeal membrane oxygenation using a CT scan and 2) identify the associated risk factors for

44 e obtained results, it may be concluded that CT scan and EBUS results have good congruence and high s

45 Patients underwent CT scan and FDG-PET at baseline and after 4 cycles (firs

46 e INRGSS stages of tumours were evaluated by CT scan and MRI.

47 Using CT scanning and manual segmentation, the orientation of

48 CT scanning and MRI were also performed.

49 Two of 5 interim (18)F-FDG PET/CT scans and 3 of 9 end-of-treatment (18)F-FDG PET/CT sc

50 dentified patients with COVID-19 using chest CT scans and assigned standardized CO-RADS and CT severi

51 When CT scans and associated clinical history are available,

52 We obtained preoperative, contrast-enhanced CT scans and corresponding pathology results from two ex

53 earning can accurately segment the spleen on CT scans and may help radiologists to detect abnormal sp

54 achanna gollum based on high-resolution nano-CT scans and one cleared and stained specimen of this re

55 PET/CT scans and pathology findings were available for 270 N

56 volume and transit times were assessed with CT scans and radiopaque markers.

57 The model remained robust on external CT scans and scans demonstrating ventricular enlargement

58 Clinically indicated CT scans and serum laboratory studies.

59 Micro-CT scans and transverse sections demonstrate the absence

60 igated: a public benchmarking dataset of 302 CT scans and two in-house datasets with a total of 238 C

61 terized by the 3D X-ray Computed Tomography (CT) scan and used to train a Random Forest (RF) classifi

62 ollow-up period and had at least 1 follow-up CT scan, and 2772 had at least 1 follow-up spirometric a

63 n at baseline, a posttreatment (166)Ho SPECT/CT scan, and another (18)F-FDG PET/CT scan at the 3-mo f

64 lipoprotein, and liver attenuation index on CT scan, and similar future liver remnant.

65 antified under electron microscopy and micro-CT scans, and used to model rotational, drag and lift fo

66 dy planar scans, focused-field-of-view SPECT/CT scans, and whole-body (124)I-MIBG PET scans found 25,

67 a, 2,557 with full-lung computed tomography (CT) scans, and 5,710 with cardiac CT scans.

68 nd then fine-tuned on a small dataset of 438 CT scans annotated for appendicitis.

69 study, cone-beam single projection and axial CT scans are modeled with a software package-DOCTORS, wh

70 Chest CT scans are one of the most common medical imaging proc

71 An estimated 4-5 million CT scans are performed in the USA every year to investig

72 (EBUS) and spiral chest computed tomography (CT) scan are important methods in the prediction of infi

73 Plain chest X-rays and computed tomography (CT) scan are the main imaging techniques and are the ini

74 ve value (NPV) were calculated for MRI using CT scan as a reference standard.

75 readers deemed 66% of the (11)C-choline PET/CT scans as positive.

76 readers deemed 66% of the (11)C-choline PET/CT scans as positive.

77 The model generalized to external CT scans as well as scans demonstrating iNPH.Supplementa

78 e RAI relates is not covered by a diagnostic CT scan (as part of the (18)F-FDG PET/CT examination) wa

79 t of 3 patients had a delayed whole-body PET/CT scan at 180 min.

80 nd II studies who underwent an (18)F-FDG PET/CT scan at baseline, a posttreatment (166)Ho SPECT/CT sc

81 )Ho SPECT/CT scan, and another (18)F-FDG PET/CT scan at the 3-mo follow-up were included for analysis

82 ans and tumors were analyzed by serial SPECT/CT scans at 3 time points (30 min, 2 h, and 6 h) after i

83 cancers underwent serial (68)Ga-FAPI-46 PET/CT scans at 3 time points after radiotracer injection: 1

84 or 10 mg) as a single dose, followed by PET/CT scans at approximately 1-2, 6-8, 24, 48, and 96-144 h

85 (CD4+ count <100 cells/uL) underwent FDG-PET/CT scans at baseline and 4-8 weeks after ART initiation.

86 (18)F-FDG PET/CT scans at baseline and at 12-14 wk after nCRT were qua

87 cancers underwent serial (68)Ga-FAPI-46 PET/CT scans at three time points following radiotracer inje

88 ated using cross-sectional image analysis of CT-scans, at the level of the third lumbar vertebra (L3)

89 We also reviewed 311 chest CT scans belonging to a control group of patients who di

90 and pretreatment contrast material-enhanced CT scans between 2004 and 2018 were included.

91 astatic melanoma who underwent (18)F-FDG PET/CT scans both before and after treatment to evaluate tre

92 We evaluated the response to treatment with CT scan by means of response evaluation criteria in soli

93 rst 24 hours, noncomparative repeat cerebral CT scan, chronic anticoagulation, administration of fibr

94 Conclusion Elastic registration of CT scans combined with a deep learning classifier aided

95 ished, and the recent combination of PET and CT scanning combines the assessment of tumor physiologic

96 OVID-19 via RT-PCR who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients,

97 d from the algorithm, by analyzing the whole CT scan, correlated with the diffusion lung capacity for

98 CT scan criteria were associated with a 33% rate of over

99 cross-sectional, T1-weighted muscle MRI and CT-scan data from 168 patients with genetically confirme

100 PET/CT scans decreased by an average of 36%, whereas sentine

101 data and new patients with only 1 or 2 SPECT/CT scans demonstrate less bias on average and significan

102 ound Classification of lung cancer screening CT scans depends on measurement of lung nodule size.

103 A CT scan detected the injury and a covered esophageal ste

104 ed image reconstruction for (18)F-DCFPyL PET/CT scans did not increase BCR localization in patients w

105 Whole-body (18)F-FDG PET and CT scans did not show neoplasia.

106 n to approximately 3.7 mSv from one low-dose CT scan done for attenuation correction.

107 ts who underwent a total of 32 (18)F-FDG PET/CT scans due to clinical suspicion of PTLD within an 8-y

108 A separate 192 AAA patients with serial CT scans during AAA surveillance were identified from an

109 t vocal tract following Computed Tomography (CT) scanning, enabling the creation of a 3-D printed voc

110 male subjects by consecutive whole-body PET/CT scanning, estimation of the normalized cumulated acti

111 It can be concluded that CT scan features are not sensitive to the diagnosis.

112 CT scan findings in patients with XDR-TB are similar to

113 CT scan findings were compared for cavitary, parenchymal

114 HCC was confirmed based on characteristic CT scan findings.

115 valuate and compare the computed tomography (CT) scan findings of MDR-TB and XDR-TB patients.

116 e potential ionizing radiation exposure from CT scans for both screening and surveillance of patients

117 to assess the value of serial (18)F-FDG PET/CT scans for detecting local recurrence in patients beyo

118 the potential to aid in rapid evaluation of CT scans for differentiation of COVID-19 findings from o

119 ively paired (18)F-fluciclovine and PSMA PET-CT scans for localising biochemical recurrence of prosta

120 atients received 85 whole-body (18)F-FDG PET/CT scans for the work-up of device infection.

121 se the image quality of computed tomography (CT) scanning for the diagnosis of PAD with the lowest po

122 od can accurately synthesize a pelvis pseudo-CT scan from standard Dixon-VIBE images, allowing for ac

123 Results CT scans from 100 patients with middle cerebral artery o

124 CT scans from 109 treatment-naive patients with NSCLC (2

125 In addition, follow up CT scans from 11 pneumonia patients showed full recovery

126 masked to all clinical information read PET/CT scans from 21 healthy volunteers and 42 NET-positive

127 Results: (18)F-NaF PET/CT scans from 219 patients with PCa were included, of wh

128 e retrospectively analyzed (11)C-choline PET/CT scans from 287 patients who were enrolled in an imagi

129 e retrospectively analyzed (11)C-choline PET/CT scans from 287 patients who were enrolled onto an ima

130 ataset containing 62 normal noncontrast head CT scans from 62 patients (mean age, 73 years; age range

131 We collected questionnaires and sinus CT scans from 646 participants selected from a source po

132 es, we used a large dataset of proximal limb CT scans from across Myomorpha and Geomyoidea to examine

133 cumulative colon doses for annual CAP and AP CT scans from age 15 to 40 years ranged from 0.34 Gy (5t

134 After lung segmentation, chest CT scans from center 1 (training cohort, 162 patients [m

135 Methods: A total of 232 PCa PET/CT scans from multiple hospitals was analyzed, including

136 ines recommend true whole-body (18)F-FDG PET/CT scans from vertex to toes in pediatric lymphoma patie

137 Computerised tomography (CT) scans from patients with infra-renal AAAs were analy

138 kground Body composition data from abdominal CT scans have the potential to opportunistically identif

139 but 4 months later a scheduled surveillance CT scan identified a 1.4-cm left para-aortic lymph node

140 CT scan imagery found lung abscess in 5 (41.6%) cases.

141 ed acute respiratory distress syndrome using CT scan imaging despite a high target and close monitori

142 h hospital discharge or computed tomography (CT) scan improvement, whereas late IFN-alpha2b was assoc

143 y system, and lung recruitment assessed by a CT scan in mechanically ventilated acute respiratory dis

144 of endobronchial ultrasound and spiral chest CT scan in the prediction of infiltrating and non-infilt

145 Results A total of 11 669 CT scans in 9552 adults (mean age +/- standard deviation

146 derived from noncontrast low-dose abdominal CT scans in a generally healthy asymptomatic adult outpa

147 Opacity patterns on chest CT scans in COVID-19 are different based on sex and age,

148 s) were present on T1-weighted MRI, sCT, and CT scans in different reading sessions, with readers bli

149 Negative PET/CT scans in N0 necks was true negative in 87% and false

150 nterobserver agreement with (18)F-DCFPyL PET/CT scans in patients with BCR and low PSA values.

151 detection from elastic registration of chest CT scans in patients with systemic sclerosis (SSc).

152 graft syndrome (RAS) who underwent F-FDG PET/CT scan, in comparison with stable lung transplant recip

153 rticipants underwent at least one additional CT scan (initially indeterminate).

154 ility and less invasive nature, use of chest CT scan is more rational and is recommended in these pat

155 lung parenchyma, to identify pleural fluid; CT scanning is not usually indicated.

156 phy (PET) combined with computed tomography (CT) scan is accepted as a standard tool in the staging o

157 emission tomography/computed tomography (PET/CT) scans is a tool that allows characterization of inte

158 motion during the CT and PET parts of a PET/CT scan leads to imperfect alignment of anatomic feature

159 on, or miscellaneous], type of (18)F-FDG PET/CT scan [low-dose (18)F-FDG PET/CT or low-dose (18)F-FDG

160 CT scanning may replace routine ophthalmologic examinati

161 dures guided by 246 incremental conventional CT scans (mean, 12.5 scans per procedure).

162 ients received 2 whole-body (18)F-DCFPyL PET/CT scans (median dose, 317 MBq; uptake time, 120 min) wi

163 All PET/CT scans (n = 204) were reviewed by 1 nuclear medicine p

164 idney (n = 2) or three 10-min whole-body PET/CT scans (n = 3) immediately after injection and blood-b

165 d for the following reasons: repeat cerebral CT scan not performed within the first 24 hours, noncomp

166 ssion head CT and follow-up head dual-energy CT scans obtained after contrast material-enhanced whole

167 ll confirmed cases of COVID-19 with thoracic CT scans obtained at three hospitals from February 25, 2

168 ctively measured lung nodules from screening CT scans obtained between September 2016 and June 2018 w

169 Retrospective review of pre-TAVR CT scans obtained during 2012-2017 was conducted.

170 of metastatic disease was noted on follow-up CT scans obtained during the first 5 months of treatment

171 ve review was performed of baseline low-dose CT scans obtained in 8730 participants in the Mount Sina

172 cervix, followed by an immediate dynamic PET/CT scan of the pelvis and a delayed 1-h whole-body scan.

173 cavation, cleaning and high-resolution micro-CT scanning of the StW 573 ('Little Foot') skull has rev

174 omparative dataset of three-dimensional (3D) CT scans of 189 skulls, capturing 17 independent transit

175 Methods: Baseline (18)F-FDG PET/CT scans of 301 DLBCL patients from the REMARC trial (NC

176 ration was performed to 65 patients, and the CT scans of 45 patients (30 males, 15 females) were incl

177 Then, the data of 28 whole-body SPECT/CT scans of 7 patients who underwent (177)Lu prostate-sp

178 thered during the CT and PET parts of 28 PET/CT scans of cancer patients with 40 lesions up to 3 cm i

179 Chest CT scans of consecutive patients suspected of having COV

180 The CT scans of left metacarpal IV revealed the presence of

181 normal radiological findings on craniofacial CT scans of Mucor and Aspergillus induced AIFR could be

182 We retrospectively analysed 77 head CT scans of patients admitted from the emergency room (E

183 The system was evaluated by using 105 chest CT scans of patients admitted to the hospital with clini

184 Methods: (18)F-rhPSMA-7 PET/CT scans of patients with BCR between July 2017 and June

185 MLN measurements were obtained from chest CT scans of patients with ILD at baseline evaluation ove

186 Methods: Tumors extracted from real PET/CT scans of patients with non-small cell lung cancer ser

187 68)Ga-prostate-specific membrane antigen PET/CT scans of PCa patients were available.

188 We retrospectively reviewed the unenhanced CT scans of surgically proven cases of acute gangrenous

189 There were 101 CT scans of the abdomen or pelvis and 18 CT scans of the

190 101 CT scans of the abdomen or pelvis and 18 CT scans of the cervical spine or neck.

191 had undergone at least two unenhanced supine CT scans of the chest and pulmonary function tests (PFTs

192 aphy-ion mobility spectrometry gas analysis, CT scans of the lungs, and blood samples were obtained a

193 ith a contrast-enhanced computed tomography (CT) scan of the chest/abdomen/pelvis showed no evidence

194 bronchoscopy and chest computed tomography (CT) scans of 187 anthracotic patients.

195 lysed contrast-enhanced computed tomography (CT) scans of chest of 100 patients with previous history

196 Here, we used micro-computed tomography (mu-CT) scans of mandibles, from eight myrmecophagous specie

197 CT-scan of abdomen showed enlarged left liver lobe due t

198 Nano CT-scans of selected equatorial Pacific Ocean planktonic

199 , we recruited 450 patients with normal head CT scans (of whom 330 had negative MRI scans and 120 had

200 rs independently evaluated the (18)F-NaF PET/CT scans on a patient level using a 3-category scale (no

201 or outpatient], indication for (18)F-FDG PET/CT scanning [oncologic, infection/inflammation, or misce

202 a morphologic correlate on the corresponding CT scan or on the subsequent MRI scan.

203 positive MRI scans in patients with negative CT scans over 24 h (time between injury and venepuncture

204 Each participant underwent four PET/CT scans over the next 8 days, as well as blood chemistr

205 CT scanning parameters for patients with pancreatic neur

206 Lung CT scan performed at 5 and 45 cm H2O.

207 convolutional neural network with 4,396 head CT scans performed at the University of California at Sa

208 opportunistic role in abdominal nonenhanced CT scans performed for other clinical indications.

209 Head CT scans performed in the emergency department were asse

210 The number of CT scans performed increased from 67 million to 84 milli

211 MRI scans were performed preoperatively and CT scans postoperatively for localisation of electrodes.

212 imaged multiple times and/or with multiphase CT scan protocols.

213 Reasons are heterogeneous CT scanning protocols and the resulting technical variab

214 e and muscle imaging biomarkers derived from CT scans provided comparable performance to Fracture Ris

215 PET-CT scans quantified brown adipose tissue volume and acti

216 in reaction (RT-PCR) results obtained before CT scan reading (COVID-19 suspected on presentation); gr

217 ecting small nodules and GGOs on MR is poor; CT scan remains the imaging modality of choice for the e

218 d edentulous based on what was exposed but a CT scanning revealed that the species indeed had rounded

219 Contrast-enhanced computed tomography (CT) scan revealed a single, multiloculated liver lesion,

220 Chest computerized tomography (CT) scan, RT-qPCR, lateral flow immunochromatographic st

221 aseline CT underwent two portal venous phase CT scans: SD and RD in the same breath hold.

222 A contrast-enhanced CT scan showed a big mass of soft tissue with diffuse in

223 inclusion if plain abdominal radiography or CT scan showed diffuse free air or fluid.

224 Chest CT scans showed enhancement of interstitial density.

225 diaphragm, and spine were segmented in each CT scan slice images to construct the 3D morphology of t

226 Materials and Methods A structured CT scan survey (NCT04339686) was sent to 26 hospital rad

227 s the pandemic unfolds, leading to non-chest CT scans that may uncover unsuspected pulmonary disease.

228 luded a random sample of 2,643 (18)F-FDG PET/CT scans that were performed for various clinical reason

229 otion may be required to receive two sets of CT scans - the initial free-breathing 4-dimensional CT (

230 was to document the usefulness of total body CT scan to detect synchronous primary malignancies in ca

231 ng mice underwent a (18)F-flortanidazole PET/CT scan to determine baseline tumor hypoxia.

232 We performed dynamic PET/CT scanning to assess whether in vivo (18)F-FDG pharmaco

233 We report on the use of micro-CT scans to study, in detail, the internal structures an

234 phthalmologist, masked to the results of the CT scan, to identify retinal and vitreous hemorrhages co

235 can for tumor motion estimation and a second CT scan under appropriate motion management such as brea

236 od and extent of pulmonary COVID-19 on chest CT scans using the COVID-19 Reporting and Data System (C

237 was graded semi-quantitatively on admission CT scans using the modified Fisher scale (grades: 0, no

238 n were calculated from dynamic (18)F-FDG PET/CT scans using the Patlak analysis.

239 ivity, specificity, and accuracy of EBUS and CT-scan versus fine needle aspiration pathology results

240 strated that the congruence between EBUS and CT scan was 80.5% (p = 0.0001).

241 For validation purposes, a low-dose CT scan was also performed.

242 Each chest CT scan was evaluated using RSNA guidelines by 9 readers

243 volumab treatment, the first follow-up chest CT scan was performed and showed new findings in the med

244 A CT scan was performed at the end of the procedure and al

245 A lung CT scan was performed during breath-holding pressure at

246 intravenously 30 min later, and a second PET/CT scan was performed to assess changes in tumor hypoxia

247 An outpatient CT scan was performed to characterize the liver lesions.

248 CT scan was performed within 4 days after decannulation.

249 on of (18)F-BMS-986192, a 60-min dynamic PET/CT scan was started, followed by a 30-min whole-body PET

250 Subsequently, chest CT scanning was performed as part of routine 6-month pos

251 risk category, the kappa value for all test CT scans was 0.90 (95% confidence interval [CI]: 0.89, 0

252 The presence of fibrosis on baseline CT scans was an independent predictor of adverse events

253 stablished after laparotomy and rereading of CT scans was that of emphysematous cholecystitis associa

254 on mass on conventional computed tomography (CT) scan was measured as secondary outcome.

255 e sensitivity, specificity, and accuracy for CT scan were 100%, 22.6%, and 40%, respectively, and the

256 inct radiomics features detected at baseline CT scan were associated with subsequent development of T

257 ethods: Patients referred for a clinical PET/CT scan were enrolled in this study, received a weight-b

258 ients who underwent a baseline (18)F-FDG PET/CT scan were identified.

259 dence of intracranial hemorrhage on cerebral CT scan were included.

260 Static (18)F-fluoride PET/CT scans were acquired 60 min after injection, before an

261 ors were administered (132)La-NM600, and PET/CT scans were acquired up to 24 h after injection.

262 al discharge), and "no acquired impairment." CT scans were analyzed for skeletal muscle and fat area

263 ns and 3 of 9 end-of-treatment (18)F-FDG PET/CT scans were false-positive.

264 d white blood cell single photon emission CT/CT scans were independently analyzed blinded to the pati

265 elected, and the arteries and veins on their CT scans were manually annotated by five experienced obs

266 tients with corresponding (68)Ga-PSMA-11 PET/CT scans were matched.

267 lume, volume of extra-axial haematomas) from CT scans were measured and correlated with epochs of con

268 n of 100 MBq of the tracer, 4 successive PET/CT scans were obtained at 30, 60, 120, and 240 min after

269 (18)F-NaF PET/CT scans were obtained at baseline (PET1), week 13 (PET2

270 As part of clinical practice, chest CT scans were obtained for primary work-up and scored us

271 Static (18)F-FDG PET/CT scans were obtained immediately after dynamic PET/CT

272 Of 261 patients randomized, no follow-up CT scans were obtained on 7 (3%), leaving a final analys

273 CT scans were performed at a median of 2 days (1-3 d) af

274 Follow-up (18)F-FDG PET/CT scans were performed at a median of 89 d (interquarti

275 By study design, PET/CT scans were performed at baseline and before starting

276 rostate-specific membrane antigen (PSMA) PET/CT scans were performed followed by radical prostatectom

277 n-pelvic (AP) and chest-abdomen-pelvic (CAP) CT scans were performed with either a three-phase (n = 1

278 ); group 2 had RT-PCR results obtained after CT scans were read (COVID-19 not suspected).

279 All CT scans were read for signs of COVID-19 related pulmona

280 Twenty-one response assessment (18)F-FDG PET/CT scans were reevaluated according to the Lugano criter

281 Methods: (68)Ga-FAPI PET/CT scans were requested by various referring physicians

282 Methods: (18)F-NaF PET/CT scans were retrieved from all patients who participat

283 nical records, laboratory results, and chest CT scans were retrospectively reviewed for nine pregnant

284 Postprocedural CT scans were reviewed for the presence of contrast with

285 Baseline and follow-up CT scans were segmented to derive liver and tumor volume

286 ds: One hundred forty baseline (18)F-FDG PET/CT scans were selected from U.K. and Dutch studies on DL

287 ively compared on admission and serial chest CT scans were semi-quantitively evaluated between two gr

288 (123)I-ioflupane single-photon emission CT scans were used in a cross-sectional study to measure

289 Morphologic changes on CT scans were visually assessed by two observers and cat

290 Computed tomography (CT) scans were performed to localize the circumferential

291 using honey bee models, obtained using micro-CT scanning, were implemented to determine RF absorbed p

292 The patient underwent chest X-ray and CT scan, which showed right sided pleural thickening cou

293 both standard and low-dose contrast enhanced CT scans, which were categorized as normal, uncomplicate

294 1/15/20 to 3/30/20 identified 89 consecutive CT scans whose radiological report mentioned COVID-19.

295 Individuals underwent PET/CT scanning with a 120-min dynamic PET scan centered on

296 h metastatic prostate cancer underwent 2 PET/CT scans with (68)Ga-PSMA-HBED-CC within 14 d (mean, 6 +

297 metastatic prostate cancer underwent two PET/CT scans with (68)Ga-PSMA-HBED-CC within 14 days (mean 6

298 AI-based algorithms can readily identify CT scans with COVID-19 associated pneumonia, as well as

299 with TBI who had a clinically indicated head CT scan within 24 h of injury at 18 level 1 trauma centr

300 e (reference test) and PSMA (index test) PET-CT scans within 15 days.